This announcement is a separate document:
香雪制药：关于公司债券可能被实施投资者适当性管理的风险提示公告
Xiangxue Pharmaceutical: Risk warning announcement on the possibility that corporate bonds may be subject to investor appropriateness management
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.